Skip to content

Prognostic value of coronary quantitative flow ratio in patients treated with drug coated balloon

Prognostic value of coronary quantitative flow ratio in patients treated with drug coated balloon

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074927
Enrollment
Unknown
Registered
2023-08-21
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

The target lesion failure (TLF) group ( target lesion failure (cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization) after DCB treatment):None
the no target lesion failure (non-TLF) group (no target lesion failure (cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization) after DCB treatment):Non

Sponsors

Affiliated Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: The patient's age = 18 years old, according to relevant guidelines or consensus and the experience of the operator, the target lesion vessels were treated with DCB, and the follow-up was at least 12 months after treatment.

Exclusion criteria

Exclusion criteria: (1) Patients who accepted stent treatment due to NHLBI classification D-F dissection and/or residual stenosis >30% after DCB dilation; (2) True bifurcation lesions; (3) Stent and DCB treatment are implanted at the same time in the same vessel; (4) The image quality is poor and QFR analysis cannot be performed.

Design outcomes

Primary

MeasureTime frame
cardiac death;target vessel myocardial infarction;ischemia-driven target lesion revascularization;

Countries

China

Contacts

Public ContactKan Zhang

Affiliated Beijing Friendship Hospital, Capital Medical University

zhangkan@ccmu.edu.cn+86 134 6657 2599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026